Cargando…
A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives
Phagemid particles based on the Neisseria gonorrhoeae filamentous phage NgoΦ6 were used as a vaccine delivery system. We demonstrate that the host proteins incorporated into/associated with these particles can be encoded by chromosomal genes of the host bacterium or from plasmids able to replicate a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096494/ https://www.ncbi.nlm.nih.gov/pubmed/35572628 http://dx.doi.org/10.3389/fmicb.2022.793205 |
_version_ | 1784705989793021952 |
---|---|
author | Piekarowicz, Andrzej Kłyż, Aneta Stein, Daniel C. |
author_facet | Piekarowicz, Andrzej Kłyż, Aneta Stein, Daniel C. |
author_sort | Piekarowicz, Andrzej |
collection | PubMed |
description | Phagemid particles based on the Neisseria gonorrhoeae filamentous phage NgoΦ6 were used as a vaccine delivery system. We demonstrate that the host proteins incorporated into/associated with these particles can be encoded by chromosomal genes of the host bacterium or from plasmids able to replicate as an autonomous entity in the phagemid host. Phagemid particles were prepared from three types of cells, namely, Salmonella enterica ser. Typhimurium [pBSKS::Φ6fm(ST)] containing phagemid genome as an autonomous plasmid, Haemophilus influenzae Rd containing phagemid [pBSKS::Φ6fm(Hin)] integrated into the chromosome, and S. enterica ser. Typhimurium [pMPMT6::Φ6fm(ST)] containing an additional plasmid, pE1 HCV, encoding the Hepatitis C virus envelope glycoprotein E1. Approximately 200 μg of purified phage particles was used to immunize rabbits. The phagemid particles prepared from these three strains all elicited a large amount of IgG antibodies that were able to recognize bacterial host cells and proteins, as determined by ELISA and FACS analysis. The amount of specific anti-S. enterica ser. Typhimurium, anti-H. influenzae, and anti-E1 HCV antibodies elicited by vaccination was 170 μg/ml for anti-Salmonella, 80 μg/ml for anti-H. influenzae, and 65 μg/ml for anti-E1 HCV. Taken in toto, these data suggest that classical phage display methods have underestimated the potential for filamentous phage as a novel immunogen delivery system. |
format | Online Article Text |
id | pubmed-9096494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90964942022-05-13 A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives Piekarowicz, Andrzej Kłyż, Aneta Stein, Daniel C. Front Microbiol Microbiology Phagemid particles based on the Neisseria gonorrhoeae filamentous phage NgoΦ6 were used as a vaccine delivery system. We demonstrate that the host proteins incorporated into/associated with these particles can be encoded by chromosomal genes of the host bacterium or from plasmids able to replicate as an autonomous entity in the phagemid host. Phagemid particles were prepared from three types of cells, namely, Salmonella enterica ser. Typhimurium [pBSKS::Φ6fm(ST)] containing phagemid genome as an autonomous plasmid, Haemophilus influenzae Rd containing phagemid [pBSKS::Φ6fm(Hin)] integrated into the chromosome, and S. enterica ser. Typhimurium [pMPMT6::Φ6fm(ST)] containing an additional plasmid, pE1 HCV, encoding the Hepatitis C virus envelope glycoprotein E1. Approximately 200 μg of purified phage particles was used to immunize rabbits. The phagemid particles prepared from these three strains all elicited a large amount of IgG antibodies that were able to recognize bacterial host cells and proteins, as determined by ELISA and FACS analysis. The amount of specific anti-S. enterica ser. Typhimurium, anti-H. influenzae, and anti-E1 HCV antibodies elicited by vaccination was 170 μg/ml for anti-Salmonella, 80 μg/ml for anti-H. influenzae, and 65 μg/ml for anti-E1 HCV. Taken in toto, these data suggest that classical phage display methods have underestimated the potential for filamentous phage as a novel immunogen delivery system. Frontiers Media S.A. 2022-04-28 /pmc/articles/PMC9096494/ /pubmed/35572628 http://dx.doi.org/10.3389/fmicb.2022.793205 Text en Copyright © 2022 Piekarowicz, Kłyż and Stein. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Piekarowicz, Andrzej Kłyż, Aneta Stein, Daniel C. A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives |
title | A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives |
title_full | A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives |
title_fullStr | A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives |
title_full_unstemmed | A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives |
title_short | A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives |
title_sort | new vaccination method based on phage ngoφ6 and its phagemid derivatives |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096494/ https://www.ncbi.nlm.nih.gov/pubmed/35572628 http://dx.doi.org/10.3389/fmicb.2022.793205 |
work_keys_str_mv | AT piekarowiczandrzej anewvaccinationmethodbasedonphagengoph6anditsphagemidderivatives AT kłyzaneta anewvaccinationmethodbasedonphagengoph6anditsphagemidderivatives AT steindanielc anewvaccinationmethodbasedonphagengoph6anditsphagemidderivatives AT piekarowiczandrzej newvaccinationmethodbasedonphagengoph6anditsphagemidderivatives AT kłyzaneta newvaccinationmethodbasedonphagengoph6anditsphagemidderivatives AT steindanielc newvaccinationmethodbasedonphagengoph6anditsphagemidderivatives |